
Sarah C. Glover
Professor
Department:
SOM-Medicine
Email:
scglover@umc.edu
Work Phone:
(601) 984-4540
Biography
Dr. Sarah Glover grew up in the Pacific Northwest, obtained a Bachelor of Arts in chemistry at Seattle Pacific University, and received her medical degree from Midwestern University in Chicago, Illinois. Dr. Glover completed her Internal Medicine Residency and GI fellowship at the University of Illinois at Chicago and then joined their faculty from 2004 to 2010. From 2011 until 2018, she served as faculty at the University of Florida in Gainesville. Since January 2019, Dr. Glover has served as the Division Chief for Digestive Diseases at the University of Mississippi Medical Center in Jackson.
Dr. Glover’s clinical practice is focused on the medical management of Crohn’s Disease, ulcerative colitis, eosinophilic and mast cell disorders that impact the GI tract including hereditary alpha tryptasemia. Dr. Glover has current collaborative NIH funding and is active in industry-sponsored clinical trials. Her laboratory focuses on innate immune mechanisms of gut inflammation and COVID-19 immune responses.
Education
Midwestern University, DO, Doctor of Osteopathic Medicine | 1998 |
Seattle Pacific University, BA, chemistry | 1994 |
Specialty Certification Licensure
Licensure, Doctor of Osteopathic Medicine, Mississippi State Board of Medical Licensure | 12/2018 - 06/2020 |
Certification, American Board of Internal Medicine | 11/2004 - Present |
Current Positions
Professor, School of Medicine, Department of Medicine | 09/2022 - Present |
The University of Mississippi Medical Center Jackson, Mississippi 39216 |
Academic Appointments or Other Previous Appointments
Division Director, University of Mississippi Medical Center, School of Medicine, Department of Medicine | 01/2019 - 09/2022 |
Adjunct Associate Professor, University of Florida, School of Medicine, Department of Medicine | 01/2019 - 2020 |
Associate Professor, University of Florida, School of Medicine, Department of Medicine | 06/2013 - 01/2019 |
Assistant Professor, University of Florida, School of Medicine, Department of Medicine | 2011 - 05/2013 |
Assistant Professor, University of Illinois at Chicago, School of Medicine, Department of Medicine | 06/2004 - 12/2010 |
Sponsored Program Funding
Extramural, Clinical and Pre-Clinical Predictors of Response to Gattex in Short Bowel Syndrome, Takeda | 01/2020 - 01/2022 |
Extramural, R21 DE028378-01A1 Innate Immune Mechanisms of Peridontal Disease in Inflammatory Bowel Disease, National Institute of Dental and Craniofacial Research | 09/2019 - 08/2021 |
Extramural, A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of BMS-986165 in Subjects with Moderate-to-Severe Crohn's Disease, Bristol Myers Squibb | 06/2019 - 05/2021 |
Extramural, R01DK073338 Role of Bacteria in Colitis-Associated Colon Cancer, National Institute of Diabetes and Digestive and Kidney | 07/2018 - 01/2019 |
Extramural, R21 TR002639-01A1 Repurposing Pharmacological Agents for Inherited Mast Cell Disorders of the Gut, NCATS | 09/2017 - 06/2021 |
Extramural, Pfizer Pilot Research Award in Inflammatory Bowel Disease: Defective STAT3 Signaling in Inflammatory Bowel Disease, American Gastroenterological Association | 07/2017 - 06/2018 |
Extramural, RO1 CA113975 PI Glover Role of Surface Roughness in Regulating Tumor Cell Behavior, National Cancer Institute | 09/2008 - 06/2013 |
Extramural, T32 DK007788-03 Molecular Training in Gastroenterology and Heptaology, National Institute of Diabetes and Digestive Health | 08/2000 - 06/2005 |
Presentations
Poster Presentation, Hospitalization and Surgery Rates in Patients Awaiting Approval of Biologics or Small Molecules for, American College of Gastroenterology, Charlotte, NC | 10/2022 |
Poster Presentation, Hereditary Alpha Tryptasemia May Act as a Disease Modifier in Inflammatory Bowel Disease, American College of Gastroenterology, Charlotte, NC | 10/2022 |
Poster Presentation, Features of Environmental Dust Exposure Induced Lung Disease Regulated by MyD88 Result in a Prolonged Adaptation Response, American Academy of Allergy, Asthma & Immunology (AAAAI), Philadelphia, PA | 03/2020 |
Poster Presentation, E. COLI SEPSIS FOLLOWING FMT IN AN IGA DEFICIENT IBD SUBJECT, American College of Gastroenterology, San Antonio, Texas | 11/2019 |
Poster Presentation, REAL WORLD USE OF TACROLIMUS IN COMBINATION WITH BIOLOGICALS IS BENEFICIAL IN THE TREATMENT OF IBD, American College of Gastroenterology, San Antonio, Texas | 10/2019 |
Poster Presentation, INCREASED MUCOSAL INNATE IMMUNE ACTIVATION IN HEREDITARY ALPHA TRYTPASEMIA SUBJECTS IS PREDICTIVE OF CLINICAL RESPONSE TO TOFACITANIB THERAPY, American College of Gastroenterology, San Antonio, TX | 10/2019 |
Poster Presentation, Inhibition of Intestinal Epithelial Cell Pyroptosis and Associated Mucosal Barrier Defects is a Potential Therapeutic Mechanism of Action for Mesalamine in IBD, Digestive Disease Week, San Diego, CA | 05/2019 |
Poster Presentation, Identification of a Unique Population of GI Mast Cells in a Subset of Patients with Mast Cell Activation Syndrome, Digestive Disease Week, San Diego, CA | 05/2019 |
National and International Invited Seminars/Lectures, Ileal Biopsy Epithelial Cell Pyrotosis Predicts Clinical Response to Vedolizumab Therapy in Crohn’s Disease, Digestive Disease Week, San Diego, CA | 05/2019 |
Poster Presentation, Mast Cells in Patients with Hereditary α-Tryptasemia Promote HLA-DR Expression and a Th2-Polarizing Microenvironment in the Gastrointestinal Tract, American Association of Immunologists, San Diego, California | 05/2019 |
Poster Presentation, Predictors of 30 day readmission following major abdominal surgery for Crohn’s Disease, AMERICAN SOCIETY OF COLON AND RECTAL SURGEONS, Nashville, TN | 05/2018 |
Poster Presentation, Evaluating the impact of vedolizumab of postoperative complications in Inflammatory Bowel Disease Patients, American Society of Colon and Rectal Surgeons, Nashville, TN | 05/2018 |
Honors, Awards, and Recognition
Excellence in Research Gold Award, UMMC | 2022 |
Councilor, Southern Society for Clinical Investigation | 2021 |
Excellence in Research Silver Award, University of Mississippi Medical Center | 2020 |
Fred Allison, Jr MD Research Award, Department of Medicine University of Mississippi Medical Center | 2020 |
Fellow, Southern Society for Clinical Investigation | 2019 |
Category Award (Small Intestine) for Abstract Entitled: CD117+ Exosomes and Mast Cells From Hereditary Alpha Tryptasemia Patients Reveal Unique Phosphorylation, Lipidomics and Proteomics Profiles, American College of Gastroenterology | 2018 |
Fellow, American Gastroenterological Association | 2015 |
University of Illinois Hospital, Class Act Award | 2009 |
Stem Cell Conference Travel Award, American Gastroenterological Association | 2006 |
3rd Place, Fellow and Resident Research Competition, Chicago Society of Gastroenterology | 2003 |
Professional Membership and Service
Mississippi State Medical Association, Member | 2019 - Present |
American Federation for Medical Research, Member | 2019 - Present |
Southern Society for Clinical Investigation, Member | 2019 - Present |
American Gastroenterological Association, Fellow | 2015 - Present |
Clinical Immunology Society, Member | 2013 - Present |
Federation of Clinical Immunology Societies, Member | 2013 - Present |
American College of Gastroenterology, Member | 2013 - Present |
Crohn's and Colitis Association of America, Member | 2012 - Present |
American Osteopathic Association, Member | 2004 - Present |
Committee Service
American Gastroenterological Association Research Scholar Award Review Panel 2020, Member | 2020 - 2020 |
Small Business Innovation Research Grant Applications in Digestive sciences Special Emphasis Panel Study Section, Member | 2020 - 2020 |
Community Service
Winterview Horse Farm Flora, MS, Sponsor | 08/2019 - Present |
Directed Student Learning
Dissertation Committee Chair, Aberrant ILC Plasticity Contributes to Acute Campylobacteriosis and Chronic Intestinal Inflammation Advised: Ying Tang | 2015 - 2019 |
Dissertation Committee Chair, ABERRANT INNATE IMMUNITY CONTRIBUTES TO DYSREGULATED ADAPTIVE IMMUNE RESPONSES IN PATIENTS WITH CROHN’ S DISEASE Advised: Jian Li | 2012 - 2017 |
Dissertation Committee Chair, MECHANICAL MARKERS OF COLON CANCER A DIAGNOSTIC MODEL Advised: Shruthi Bharadwaj | 2009 - 2013 |
Master's Thesis Committee Chair | 2008 - 2010 |
Dissertation Committee Chair, The Role of ROCK in Colon Cancer Invasion Using Three-Dimensional Collagen I Microenvironments Advised: Ramana Vishnubhotla | 2008 - 2012 |
Master's Thesis Committee Chair, Advised: Rebecca Mecum | 2006 - 2008 |
Fellows supervised
University of Florida, Research Advisor, 4 fellows supervised, Gastroenterology | 08/2011 - 01/2020 |
Residency Training
Internal Medicine, Research Advisor | 2019 - 05/2019 |
Internal Medicine, Research Advisor | 2014 - 06/2016 |